FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

32163811000001106: Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
96970201000001116 Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
96970301000001113 Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Is a Product containing precisely erythromycin 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has specific active ingredient Erythromycin ethylsuccinate true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) 28 tablet 2 x 14 tablets Has AMP True Erythromycin ethyl succinate 500mg tablets (Dawa Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start